To our knowledge, this is the first study reporting on the regulation of the matriptase/HAI-1 ratio by specific (i.e., siRNA) and non-specific (i.e., cisplatin) targeting associated with decreasing matriptase expression in endometrial cancer cells. Here, ST14 is linked to endometrial cancer.